Expression Vectors Market By Host Type (Bacterial Expression Vectors (E. Coli Expression Vectors, and Other Bacterial Expression Vectors), Mammalian Expression Vectors (CHO Expression Vectors, and Other Mammalian Expression Vectors), Insect Expression Vectors (Baculovirus Expression Vectors, and Other Insect Expression Vectors), Yeast Expression Vectors (K. Lactis Expression Vectors, Pichia Pastoris Expression Vectors, Saccharomyces Cerevisiae Expression Vectors, and Other Yeast Expression Vectors), and Other Expression Vectors), By Application (Therapeutic Applications, Research Applications, and Industrial Applications), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (Cros) and Contract Manufacturing Organizations (Cmos), Academic Research Institutes, and Other End Users), and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI386920 | Publish Date: May 2024 | No. of Pages: 180

Global Expression Vectors Market Market Size

Estimated at US$398.3 million in 2024, the expression vectors market is expected to expand at a compound annual growth rate (CAGR) of 6.1% to reach US$720.6 million by 2034.

A plasmid or virus intended for gene expression in cells is typically an expression vector, also called an expression construct. A target cell is given a specific gene via a vector, which can then use the cell's protein synthesis machinery to make the gene's encoded protein. Expression vectors are the fundamental tools used in biotechnology to make proteins.